fashion -WSS

fashion

author：entertainment 2025-10-01 07:40:30 - browse：537

Closeup of a human brain affected by Alzheimer's disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. — A brain affected by Alzheimer's disease, at the Museum of Neuroanatomy at the University at Buffalo. David Duprey/AP

Investigators on Wednesday released the first detailed case report about a patient who died after receiving lecanemab, providing a new glimpse into safety concerns surrounding the closely watched experimental Alzheimer’s drug.

An unpublished version of the report was previously written about by Science in November, one of three deaths from the lecanemab trials revealed by Science and STAT. But the published version, in the New England Journal of Medicine, will allow doctors to evaluate the case as they consider whether and how to use a treatment that could be approved by the FDA as soon as this week.

This “will have greater impact on clinicians because it is peer-reviewed and published in the New England Journal,” said Lon Schneider, an Alzheimer’s expert at University of Southern California, who was not affiliated with the work.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Explaining an after

hotspot

WSS

A letter from the executive editor: STAT UnitedHealth investigation

Brain injuries and the importance of a second opinion

Bill would allow buprenorphine prescription for addiction via telehealth

Cancer diagnosis changes perspective doctor, former hospital CEO

Type 2 diabetes prevention programs work at large scale: study

Medical school prerequisites are outdated

leisure time

fashion

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Type 2 diabetes prevention programs work at large scale: study

Affirmative action in medical school literally saved lives

Type 2 diabetes prevention programs work at large scale: study

What does generative AI mean for health care? We asked experts

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Medicare details structure of new drug price negotiation program

Live blog: Hearing on CRISPR

DIEP, the 'gold standard' of breast reconstruction, is under threat

Lung cancer screening guidelines updated for cigarette smokers

focus

After decades in use, heart stents finally beat placebo

Live blog: Hearing on CRISPR

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

What is microchimerism and how does it affect maternal health?

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Infant mortality in U.S. rose last year for first time in decades: CDC

focus

knowledge

hotspot

hotspot